| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CMDC.201600545 |
| P698 | PubMed publication ID | 28071858 |
| P2093 | author name string | Jing Zhao | |
| Ran Li | |||
| Xin Huang | |||
| Fei Xie | |||
| Yuanying Jiang | |||
| Dazhi Zhang | |||
| Chengxu Zang | |||
| Maomao An | |||
| Tingjunhong Ni | |||
| Zhan Cai | |||
| P2860 | cites work | Analysis of membrane topology and identification of essential residues for the yeast endoplasmic reticulum inositol acyltransferase Gwt1p | Q27937181 |
| Fundament and Prerequisites for the Application of an Antifungal TDM Service | Q28085352 | ||
| Efficacy of oral E1210, a new broad-spectrum antifungal with a novel mechanism of action, in murine models of candidiasis, aspergillosis, and fusariosis | Q35270948 | ||
| E1210, a new broad-spectrum antifungal, suppresses Candida albicans hyphal growth through inhibition of glycosylphosphatidylinositol biosynthesis | Q35689250 | ||
| Abolishing Cell Wall Glycosylphosphatidylinositol-Anchored Proteins in Candida albicans Enhances Recognition by Host Dectin-1. | Q35745515 | ||
| Chemical Genomics-Based Antifungal Drug Discovery: Targeting Glycosylphosphatidylinositol (GPI) Precursor Biosynthesis | Q36539252 | ||
| Invasive fungal infections in congenital immunodeficiencies | Q37788798 | ||
| Emerging moulds: epidemiological trends and antifungal resistance | Q37889387 | ||
| Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment | Q37971085 | ||
| The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012. | Q38025819 | ||
| Safety and interactions of new antifungals in stem cell transplant recipients. | Q38036740 | ||
| In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds | Q38627150 | ||
| In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods | Q38725931 | ||
| New insights into the functions of PIGF, a protein involved in the ethanolamine phosphate transfer steps of glycosylphosphatidylinositol biosynthesis | Q38970512 | ||
| Inhibiting GPI anchor biosynthesis in fungi stresses the endoplasmic reticulum and enhances immunogenicity | Q39326660 | ||
| New developments in invasive fungal disease | Q39653795 | ||
| First step of glycosylphosphatidylinositol (GPI) biosynthesis cross-talks with ergosterol biosynthesis and Ras signaling in Candida albicans | Q41925698 | ||
| In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method | Q42731754 | ||
| The Candida albicans homologue of PIG-P, CaGpi19p: gene dosage and role in growth and filamentation | Q43006198 | ||
| A prodrug approach towards the development of tricyclic-based FBPase inhibitors | Q43111809 | ||
| Attributable mortality of nosocomial candidemia, revisited | Q44386169 | ||
| Medicinal genetics approach towards identifying the molecular target of a novel inhibitor of fungal cell wall assembly | Q44444977 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 319-326 | |
| P577 | publication date | 2017-01-10 | |
| P1433 | published in | ChemMedChem | Q2962252 |
| P1476 | title | Synthesis and Biological Evaluation of Novel 2-Aminonicotinamide Derivatives as Antifungal Agents | |
| P478 | volume | 12 |
| Q97644483 | 11g, a Potent Antifungal Candidate, Enhances Candida albicans Immunogenicity by Unmasking β-Glucan in Fungal Cell Wall |
| Q46248402 | Chemogenomic profiling of the fungal pathogen Candida albicans |
| Q39375330 | Drugs currently under investigation for the treatment of invasive candidiasis |
Search more.